1. Home
  2. GLPG vs CASH Comparison

GLPG vs CASH Comparison

Compare GLPG & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • CASH
  • Stock Information
  • Founded
  • GLPG 1999
  • CASH 1954
  • Country
  • GLPG Belgium
  • CASH United States
  • Employees
  • GLPG N/A
  • CASH N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • CASH Major Banks
  • Sector
  • GLPG Health Care
  • CASH Finance
  • Exchange
  • GLPG Nasdaq
  • CASH Nasdaq
  • Market Cap
  • GLPG 1.8B
  • CASH 1.8B
  • IPO Year
  • GLPG 2005
  • CASH N/A
  • Fundamental
  • Price
  • GLPG $27.87
  • CASH $80.47
  • Analyst Decision
  • GLPG Sell
  • CASH Buy
  • Analyst Count
  • GLPG 4
  • CASH 2
  • Target Price
  • GLPG $25.33
  • CASH $92.00
  • AVG Volume (30 Days)
  • GLPG 259.2K
  • CASH 188.9K
  • Earning Date
  • GLPG 07-23-2025
  • CASH 07-23-2025
  • Dividend Yield
  • GLPG N/A
  • CASH 0.27%
  • EPS Growth
  • GLPG N/A
  • CASH 10.71
  • EPS
  • GLPG N/A
  • CASH 7.36
  • Revenue
  • GLPG $311,493,731.00
  • CASH $731,383,000.00
  • Revenue This Year
  • GLPG $0.78
  • CASH $13.95
  • Revenue Next Year
  • GLPG N/A
  • CASH $5.74
  • P/E Ratio
  • GLPG N/A
  • CASH $9.91
  • Revenue Growth
  • GLPG 18.32
  • CASH 6.51
  • 52 Week Low
  • GLPG $22.36
  • CASH $55.86
  • 52 Week High
  • GLPG $31.23
  • CASH $86.00
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 51.86
  • CASH 59.54
  • Support Level
  • GLPG $26.62
  • CASH $75.82
  • Resistance Level
  • GLPG $29.28
  • CASH $78.01
  • Average True Range (ATR)
  • GLPG 0.58
  • CASH 1.55
  • MACD
  • GLPG -0.16
  • CASH 0.32
  • Stochastic Oscillator
  • GLPG 54.51
  • CASH 98.45

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

Share on Social Networks: